Intellia pauses gene therapy trials after patient suffers liver injury, shares slide
By Padmanabhan Ananthan (Reuters) -Intellia Therapeutics has temporarily stopped dosing and patient screening in two late-stage studies of its gene ...
By Padmanabhan Ananthan (Reuters) -Intellia Therapeutics has temporarily stopped dosing and patient screening in two late-stage studies of its gene ...